J&J agrees to buy Numab subsidiary Yellow Jersey and its NM26 bispecific antibody for atopic dermatitis in a $1.25bn deal.

Atopic dermatitis, also known as atopic eczema, is a chronic inflammatory familial disease of the skin. It is characterized by an increased ability to form immunoglobulin E and a tendency to ...